Reporter Oct 2 2015
Oct. 1, 2015—Vanderbilt University has received a contract from the Centers for Medicare and Medicaid Services (CMS) for up to $28 million over four years to help more than 4,000 clinicians in the Southeast transform their clinical practices in ways that improve quality of patient care and hold down costs.
Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
Oct. 1, 2015—A few thousand families in the Metro Nashville Public Schools system will now have computers at home, thanks to Vanderbilt University Medical Center’s donation of 3,800 lightly used computers.
Oct. 1, 2015—Animal Research Information Enterprise System (ARIES), a new online system for submitting animal research protocols, will be launched at Vanderbilt University on Oct. 12.
Oct. 1, 2015—Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.
Oct. 1, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.
Oct. 1, 2015—Woodrow Myers Jr., M.D., chief executive officer of Corizon Health, will be the keynote speaker at the 14th annual Levi Watkins Jr. Lecture.